how to keep weight off after stopping glp 1 medication Maintain Loss GLP-1 – KETO-MOJO The GLP-1 Exit Strategy |

Choose Mini for hydration + nausea relief, Plus for deeper nutrient replenishment, and Max for the strongest antioxidant recovery support

How the body converts fat into usable energy

Medications Certain medications can alter the way your taste buds function, resulting in a metallic or metallic-like taste

By breaking food down more thoroughly before swallowing, you make the stomachs job easier

Traditionally used in Chinese and Ayurvedic medicine for centuries, berberine has gained considerable attention in recent years as a dietary supplement marketed for metabolic health, particularly blood glucose control and weight management

CagriSema vs Comparators Feature Receptor targets CagriSema Amylin/calcitonin + GLP-1 Tirzepatide (Zepbound) GIP + GLP-1 Semaglutide alone (Wegovy) GLP-1 Cagrilintide alone Amylin/calcitonin (DACRA) Feature Dosing frequency CagriSema Once weekly Tirzepatide (Zepbound) Once weekly Semaglutide alone (Wegovy) Once weekly Cagrilintide alone Once weekly Feature Maintenance dose CagriSema 2.4 mg + 2.4 mg Tirzepatide (Zepbound) Up to 15 mg Semaglutide alone (Wegovy) 2.4 mg Cagrilintide alone 2.4 mg (in REDEFINE arms) Feature Headline weight loss CagriSema 20.4% at 68 wks (REDEFINE 1, treatment-policy) Tirzepatide (Zepbound) Up to 22.5% at 72 wks (SURMOUNT-1, 15 mg arm) Semaglutide alone (Wegovy) 14.9% at 68 wks (REDEFINE 1 reference arm) Cagrilintide alone 11.5% at 68 wks (REDEFINE 1 reference arm) Feature FDA status (June 2026) CagriSema NDA filed Dec 2025